Scinovex
reviewTop 10% cited

Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery

British journal of surgery · 2001 · Vol. 88(7) · pp. 913–930
Patrick MismettiSilvy LaporteJ-Y DarmonAndréa BuchmullerH Decousus

Abstract

Asymptomatic DVT may be regarded as a reliable surrogate endpoint for clinical outcome in studies investigating thromboprophylaxis in general surgery. LMWH seems to be as effective and safe as UFH. Determination of the optimal dose regimen of LMWH for this indication requires further investigation.

Venous Thromboembolism Diagnosis and ManagementAtrial Fibrillation Management and OutcomesCentral Venous Catheters and HemodialysisMedicinePulmonary embolismDeep veinRelative riskSurgeryLow molecular weight heparinPlaceboHeparinThrombosisAsymptomatic

MeSH terms

AnticoagulantsHeparin, Low-Molecular-WeightHumansThromboembolismRandomized Controlled Trials as TopicVenous Thrombosis
Citations
646
FWCI
7.58
field-weighted impact
References
110
Percentile
98%
vs. same field & year
Citations per year
Cited by
Prevention of Venous Thromboembolism
CHEST Journal · 2004 · 5,881 citations
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
CHEST Journal · 2012 · 1,488 citations
Prevention of Venous Thromboembolism
CHEST Journal · 2008 · 3,792 citations
Prevention of VTE in Nonorthopedic Surgical Patients
CHEST Journal · 2012 · 2,091 citations
Venous thromboembolism (VTE) in Europe
Thrombosis and Haemostasis · 2007 · 1,548 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.